Free Newsletter
AZ faces $1.2B in Seroquel legal costs
Seroquel legal costs could take a $1.2 billion bite out of AstraZeneca's bottom line, the Financial Times reports. With a growing number of lawsuits from Seroquel patients and government regulators, the drugmaker may end up forking over that much in fees and settlements, the paper says.
In the fourth quarter of 2009, AstraZeneca upped its legal set-aside for Seroquel to $254 million to cover a settlement with the U.S. Justice Department over sales and marketing practices. Meanwhile, it's defending some 10,000 lawsuits in U.S. courts, covering 22,000 plaintiffs. Another 177 cases have been filed in the U.S. Plus, it's dealing with class actions in Canada and patent challenges in the U.S., Brazil and Portugal.
So lawyers are billing the company big-time, of course. According to the FT, AstraZeneca has incurred $656 million in legal costs through year's end; insurance is expected to reimburse the lion's share of that, or $521 million. It's a good thing that Seroquel accounted for $4.9 billion in sales last year, eh?
- read the FT piece
- get more from Bloomberg
Related Articles:
Astra ex: I was pressured on Seroquel
Judge tosses two more Seroquel suits
Judge: Send federal Seroquel suits to courts
AZ agrees to pay $520M in Seroquel probe
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: